Microba Life Sciences (ASX:MAP) ROCE % : -50.26% (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Microba Life Sciences ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Microba Life Sciences's annualized ROCE % for the quarter that ended in Dec. 2023 was -50.26%.

Microba Life Sciences ROCE % Historical Data

The historical data trend for Microba Life Sciences's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Microba Life Sciences ROCE % Chart

Microba Life Sciences Annual Data

Trend

Jun22

Jun23

ROCE %

-33.47

-34.52

Microba Life Sciences Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23
ROCE %	-	-	-28.14	-32.91	-50.26

Microba Life Sciences ROCE % Calculation

Microba Life Sciences's annualized ROCE % for the fiscal year that ended in Jun. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Jun. 2023 )		(A: Jun. 2022 )		(A: Jun. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Jun. 2023 )		(A: Jun. 2022 )		(A: Jun. 2023 )
	=	-12.658	/	( ( (39.479 - 5.264)	+	(46.953 - 7.824) )	/ 2 )
	=	-12.658	/	( (34.215	+	39.129)	/ 2 )
	=	-12.658	/	36.672
	=	-34.52 %

Microba Life Sciences's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	-22.964	/	( ( (46.953 - 7.824)	+	(65.236 - 12.99) )	/ 2 )
	=	-22.964	/	( ( 39.129	+	52.246 )	/ 2 )
	=	-22.964	/	45.6875
	=	-50.26 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

Microba Life Sciences (ASX:MAP) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Microba Life Sciences ROCE % Related Terms

Thank you for viewing the detailed overview of Microba Life Sciences's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Microba Life Sciences (ASX:MAP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Microba Life Sciences Ltd (ASX:MAP) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

324 Queen Street, Level 10, Brisbane, QLD, AUS, 4000

Website

https://www.microba.com

Microba Life Sciences Ltd is a commercial-stage company with technology for measuring the human gut microbiome which includes delivering gut microbiome testing services globally to consumers, clinicians, and researchers. The company's segment includes Testing Services, and Research and Development.

Microba Life Sciences (ASX:MAP) Headlines

No Headlines